Skip to content

Chinese company to develop CCR5 inhibitor with Avexa

Indian private sector patients spending 60% of income on antiretrovirals, Mumbai study finds

AZT causes genetic damage to infants; long-term cancer risk unknown

Is there any clinical benefit to staying on a failing regimen?

Mozambique: treatment access unequal between regions

Toxicity of nevirapine-based ART differs in pregnant HIV-infected Mozambican and Thai women with higher CD4 counts

Further development of resistance infrequent in patients taking tenofovir despite low-level viremia and K65R mutation

Abbott announces Kaletra price cut for lower middle-income countries, makes new offer to Thailand

Darunavir looking promising as companion for agents in new HIV drug classes